Literature DB >> 17599703

Iron in chronic brain disorders: imaging and neurotherapeutic implications.

James Stankiewicz1, S Scott Panter, Mohit Neema, Ashish Arora, Courtney E Batt, Rohit Bakshi.   

Abstract

Iron is important for brain oxygen transport, electron transfer, neurotransmitter synthesis, and myelin production. Though iron deposition has been observed in the brain with normal aging, increased iron has also been shown in many chronic neurological disorders including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. In vitro studies have demonstrated that excessive iron can lead to free radical production, which can promote neurotoxicity. However, the link between observed iron deposition and pathological processes underlying various diseases of the brain is not well understood. It is not known whether excessive in vivo iron directly contributes to tissue damage or is solely an epiphenomenon. In this article, we focus on the imaging of brain iron and the underlying physiology and metabolism relating to iron deposition. We conclude with a discussion of the potential implications of iron-related toxicity to neurotherapeutic development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599703      PMCID: PMC1963417          DOI: 10.1016/j.nurt.2007.05.006

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  177 in total

1.  FLAIR MRI of striatonigral degeneration.

Authors:  S A Block; R Bakshi
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

Review 2.  Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.

Authors:  Xueying Xu; Sokhon Pin; Muraya Gathinji; Ralph Fuchs; Z Leah Harris
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

Review 3.  Imaging iron stores in the brain using magnetic resonance imaging.

Authors:  E Mark Haacke; Norman Y C Cheng; Michael J House; Qiang Liu; Jaladhar Neelavalli; Robert J Ogg; Asadullah Khan; Muhammad Ayaz; Wolff Kirsch; Andre Obenaus
Journal:  Magn Reson Imaging       Date:  2005-01       Impact factor: 2.546

4.  Method for image-based measurement of the reversible and irreversible contribution to the transverse-relaxation rate.

Authors:  J Ma; F W Wehrli
Journal:  J Magn Reson B       Date:  1996-04

5.  Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients.

Authors:  Michael J House; Timothy G St Pierre; Kris V Kowdley; Thomas Montine; James Connor; John Beard; Jose Berger; Narendra Siddaiah; Eric Shankland; Lee-Way Jin
Journal:  Magn Reson Med       Date:  2007-01       Impact factor: 4.668

6.  MR imaging of cerebral cortical involvement in aceruloplasminemia.

Authors:  Marina Grisoli; Alberto Piperno; Luisa Chiapparini; Raffaella Mariani; Mario Savoiardo
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

7.  A transient treatment of hippocampal neurons with alpha-tocopherol induces a long-lasting protection against oxidative damage via a genomic action.

Authors:  Marie Céleste de Jesus Ferreira; Nadine Crouzin; Gérard Barbanel; Catherine Cohen-Solal; Max Récasens; Michel Vignes; Janique Guiramand
Journal:  Free Radic Biol Med       Date:  2005-10-15       Impact factor: 7.376

8.  Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis.

Authors:  Orhan Aktas; Timour Prozorovski; Alina Smorodchenko; Nicolai E Savaskan; Roland Lauster; Peter-Michael Kloetzel; Carmen Infante-Duarte; Stefan Brocke; Frauke Zipp
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

9.  Transferrin C2, metal binding and Alzheimer's disease.

Authors:  G F Van Landeghem; C Sikström; L E Beckman; R Adolfsson; L Beckman
Journal:  Neuroreport       Date:  1998-01-26       Impact factor: 1.837

10.  The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.

Authors:  D Ben-Shachar; G Eshel; J P Finberg; M B Youdim
Journal:  J Neurochem       Date:  1991-04       Impact factor: 5.372

View more
  92 in total

Review 1.  In vivo structural imaging of the cerebellum, the contribution of ultra-high fields.

Authors:  José P Marques; Rolf Gruetter; Wietske van der Zwaag
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

2.  Dopamine transporter availability in clinically normal aging is associated with individual differences in white matter integrity.

Authors:  Anna Rieckmann; Trey Hedden; Alayna P Younger; Reisa A Sperling; Keith A Johnson; Randy L Buckner
Journal:  Hum Brain Mapp       Date:  2015-11-06       Impact factor: 5.038

Review 3.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 4.  MRI in multiple sclerosis: what's inside the toolbox?

Authors:  Mohit Neema; James Stankiewicz; Ashish Arora; Zachary D Guss; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

5.  Multiple sclerosis and chronic cerebrospinal venous insufficiency: the neuroimaging perspective.

Authors:  M Filippi; M A Rocca; F Barkhof; R Bakshi; F Fazekas; O Khan; D Pelletier; A Rovira; J Simon
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-03       Impact factor: 3.825

6.  Real-time Correction of Motion and Imager Instability Artifacts during 3D γ-Aminobutyric Acid-edited MR Spectroscopic Imaging.

Authors:  Eva Heckova; Michal Považan; Bernhard Strasser; Patrik Krumpolec; Petra Hnilicová; Gilbert J Hangel; Philipp A Moser; Ovidiu C Andronesi; Andre J van der Kouwe; Peter Valkovic; Barbara Ukropcova; Siegfried Trattnig; Wolfgang Bogner
Journal:  Radiology       Date:  2017-09-28       Impact factor: 11.105

7.  3D high spectral and spatial resolution imaging of ex vivo mouse brain.

Authors:  Sean Foxley; Miriam Domowicz; Gregory S Karczmar; Nancy Schwartz
Journal:  Med Phys       Date:  2015-03       Impact factor: 4.071

Review 8.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

Review 9.  MRI in multiple sclerosis: current status and future prospects.

Authors:  Rohit Bakshi; Alan J Thompson; Maria A Rocca; Daniel Pelletier; Vincent Dousset; Frederik Barkhof; Matilde Inglese; Charles R G Guttmann; Mark A Horsfield; Massimo Filippi
Journal:  Lancet Neurol       Date:  2008-07       Impact factor: 44.182

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.